URETERAL STENTS MARKET ANALYSIS

A ureteral stent is a thin tube that's placed in ureter to help drain urine from kidney and to aid with healing and urine drainage after kidney stone surgery or kidney related surgeries. The ureters are held open with ureteral stents, which are thin, flexible tubes. These long, thin tubes usually transport urine from the kidneys to the bladder. Ureteral stents are medical devices that are used to prevent or treat ureteral blockages. There are various types of ureteral stents, which include double pigtail suture stent (PSS) that has a hydrophobic coating to reduce encrustation and biofilm, and Multiloop ureteral stent, which is intended to temporarily facilitate drainage of urine from kidney to bladder.

Global ureteral stents market is estimated to be valued at US$ 498.2 Mn in 2022 and is expected to exhibit a CAGR of 5.6% over the forecast period (2022-2030).

Figure 1: Global Ureteral Stents Market Share (%) Analysis, By Product Type, 2022

To learn more about this report, request sample copy

Increasing incidence of kidney diseases is expected to drive  the global ureteral stents market growth over the forecast period.

Increasing incidence of kidney diseases is expected to drive the global ureteral stents market growth over the forecast period. For instance, According to data published by the United States Renal Data System (USRDS), almost 786,000 persons in the United States suffer from end-stage renal disease (ESRD), with 71% requiring dialysis and 29% requiring a kidney transplant. In 2018, 131,636 people in the United States were diagnosed with ESRD, up 2.3% from 2017. Between 2017 and 2018, the unadjusted ESRD incidence per million increased by 1.5%, however the adjusted ESRD incidence per million increased by only 0.2%.

Increasing product approvals by regulatory authorities is expected to drive the global ureteral stents market growth over the forecast period.

Increasing product approvals by regulatory authorities is expected to drive the global ureteral stents market growth over the forecast period. For instance, May 14, 2018, Allium Medical, an Israel-based medical device company that specializes in minimally invasive technologies and solutions, announced that it received regulatory clearance from the China Food and Drug Administration (CFDA) to market its portfolio of urological systems in China. The company has an exclusive strategic agreement with a distribution organization in China's urology market.

Global Ureteral Stents Market- Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper the global ureteral stents market growth, owing to delayed surgeries or elective surgeries. For instance, on July 6, 2021, according to an article published in the PLOS ONE, a scientific journal on the impact of COVID-19 on elective surgery in Finland observed data indicates that the incidence of elective surgery decreased substantially when the first COVID-19 wave began in March 2020. . In 2020, Waiting times for gastrointestinal and genitourinary disorders and neoplasms were longer.

Global Ureteral Stents Market– Restraints

Product recall for ureteral stents by market players or regulatory authorities is expected to hamper the global ureteral stents market growth over the forecast period. For instance, on November 12, 2019, Coloplast Corp announced recall of Biosoft Duo Double loop ureteral stent kit and Vortek Double loop ureteral stent kit. The reason for recall was that some pouches from this batch could become unsealed, compromising the sterility of the device. The non-sterility of device may lead to a risk of infection for the patient.

Global Ureteral Stents Market– Regional Analysis

On the basis of region, the global ureteral stents market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to witness lucrative growth in the ureteral stents market, owing to increasing prevalence of chronic kidney diseases in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), In United states chronic kidney disease (CKD) affected around 15% of the adult population, or 37 million individuals, in 2021. Adults over 65 years old (38%) have CKD more frequently than those 45–64 years old (12%) or 18–44 years old (18–44 years old) (6%). CKD affects somewhat more women (14%) than men (13%) in the United States (12%).

Figure 2: Global Ureteral Stents Market Value (US$ Mn), by Region, 2022

To learn more about this report, request sample copy

Global Ureteral Stents Market– Competitive Landscape

Major players operating in the global ureteral stents market include Boston Scientific Corporation, Allium Ltd.,  B. Braun Melsungen AG, Cook, Coloplast Corp., Medline Industries, LP., Olympus America, Pnn Medical A/S, Teleflex Incorporated, Becton, Dickinson and company, Richard Wolf GmbH, Merit Medical Systems, Biomerics, HydrUStent SA, TAEWOONG, and Applied Medical Resources Corporation.